Filing Details
- Accession Number:
- 0001225208-21-001360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-01 21:39:35
- Reporting Period:
- 2021-02-01
- Accepted Time:
- 2021-02-01 21:39:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1710625 | M Jean-Luc Lemercier | One Edwards Way Irvine CA 92614 | Cvp, Emea, Canada, Latin Amer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-01 | 13,020 | $13.98 | 152,241 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-02-01 | 7,503 | $11.35 | 159,744 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-01 | 20,523 | $83.51 | 139,221 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2021-02-01 | 7,503 | $0.00 | 7,503 | $11.35 |
Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2021-02-01 | 13,020 | $0.00 | 13,020 | $13.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-02-20 | 2021-02-19 | No | 4 | M | Direct |
26,040 | 2015-05-08 | 2021-05-07 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020.
- This transaction was executed in multiple trades at prices ranging from $83.1600 to $83.7100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.